James Noble, Director at CURAGEN CORP (CRGN), bought 20,000 shares at $2.87 ($57K) on 2007-05-08, disclosed to the SEC on 2007-05-09.
Open-market purchase of $57k CRGN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| GWPH | SELL | 2019-05-29 | $1.3M | — | Filing → |